Funding
Undisclosed · Biotech

FluoSphera raises €1.23m for preclinical testing platform

Soulmates Ventures and IndieBio New York participated in the financing.

Updated Oct 16, 2026By RoundOS Funding desk

FluoSphera raised €1.23 million in financing on January 12, with participation from Soulmates Ventures and IndieBio New York. The company develops a human-based preclinical platform for drug-safety and efficacy testing.

Funding history

Undisclosed · This round€1.2M

Sources

  1. FluoSpheraprojectstartups.com
  2. tech.eu

Similar rounds

All Biotech rounds →
Guoke Brain-Computer

Beijing startup developing non-invasive wearable brain-computer interfaces that combine brain-signal detection, decoding and neural modulation.

UndisclosedSeed · Oct 23, 2026
Star Therapeutics

Biotechnology company discovering and developing antibody therapies for diseases with significant unmet need.

$200MPrivate financing · Oct 23, 2026
Pathos AI

Clinical-stage drug developer using AI to select therapeutic assets and guide oncology trials.

$237MSeries E · Oct 23, 2026
Warp Sciences

Warp Sciences combines chemistry, AI and robotics to help drug discovery teams make and test molecules in the United States.

$215MSeries A · Oct 22, 2026

Related